SCHEMBL7843634

SCHEMBL7843634

CS(=O)(=O)c1ccccc1-c1sc(COc2cccc(Cl)c2)nc1-c1ccc(F)cc1

nearest known ligand 0.55

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 10/20 0.55
PTGS1 P23219 2/20 0.55
PPARD Q03181 7/20 0.43
PTGDR2 Q9Y5Y4 1/20 0.41
RAB9A P51151 1/20 0.40
KMT2A Q03164 1/20 0.40
ALOX5 P09917 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7842015 0.93 PTGS2 (0.55) PTGS2PTGS1PPARDRAB9AKMT2A
SCHEMBL6246548 0.93 PTGS2 (0.65) PTGS2PTGS1PPARDALOX5
SCHEMBL7833526 0.92 PTGS2 (0.48) PTGS2PTGS1PPARDALOX5
SCHEMBL7833513 0.90 PTGS2 (0.53) PTGS2PTGS1PPARDPTGDR2RAB9A
SCHEMBL7844271 0.90 PTGS2 (0.53) PTGS2PTGS1PPARDRAB9AKMT2A
SCHEMBL7839942 0.89 PTGS2 (0.47) PTGS2PTGS1PPARDALOX5
SCHEMBL7843368 0.89 PTGS2 (0.42) PTGS2PTGS1PPARDPTGDR2RAB9A
SCHEMBL7841302 0.89 PTGS2 (0.51) PTGS2PTGS1PPARDRAB9AKMT2A
SCHEMBL7843072 0.88 PTGS2 (0.52) PTGS2PTGS1PPARDALOX5
SCHEMBL8918644 0.87 PTGS2 (0.49) PTGS2PTGS1PPARDRAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1125932-A2 Substituted thiazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-22 EP disclosed
US-5668161-A Substituted thiazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 1997-09-16 US disclosed
EP-0772606-A1 SUBSTITUTED THIAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
WO-1996003392-A1 SUBSTITUTED THIAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed